Regeneron Pharmaceuticals Inc.
Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years[...]
06/26/2024 | Press release | Distributed by Public on 06/26/2024 15:32
Please select the service you want to use:
Smartlinks | City of Chicago, IL | News | Education | Local News | Politics and Policy | Government | Local Government | Jobs and Labor | Top City Municipalities
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact